Baxa Corporation is sponsoring a presentation to discuss the new sterile compounding requirements under USP Chapter 797. The Exhibitor’s Theatre presentation, “USP 797: A Practical Approach to Compliance,” will detail the most costly areas of compliance and review the necessary financial and operational resources. The program will take place on Tuesday, December 7th at the meeting of the American Society of Health-System Pharmacists (ASHP) to be held at the Orange County Convention Center in Orlando, Florida.

The presentation is expected to help pharmacy directors and operational managers better understand the design requirements for cleanrooms, isolators and laminar flow workstations and their application in meeting the environmental controls outlined for sterile compounding under the new Chapter. The program will include discussion of recommendations for avoiding errors and unnecessary cost in the development and execution of action plans for addressing the pharmacy changes to comply with USP 797.

The presenter, Eric Kastango, MBA, RPh, is a Fellow of the American Society of Health-System Pharmacists and has served on the ASHP's Council of Education Affairs and as a pharmacy surveyor for the Accreditation Commission for Health Care, Inc. (ACHC). Kastango has made more than 50 invited professional presentations on a variety of pharmacy practice topics, including USP General Chapter 797 compliance, sterile preparation and pharmacy compounding errors, quality systems and collaborative pharmacy/nursing practice models.

ASHP is a 30,000-member national organization representing pharmacists practicing in hospitals, homecare, HMOs and alternate-site facilities. The Society provides extensive published and educational resources that help pharmacists improve their professional standards and make the best use of medicines and technology for patient safety and improved outcomes. ASHP holds two annual meetings for members and industry representatives.

The complimentary educational program will be held Tuesday, December 7th in Exhibitor’s Theatre 01, Room 305A of the Orange County Convention Center in Orlando, beginning at 12:45 PM. Participants are eligible for one credit hour of Continuing Education (CEU).

About Baxa Corporation
As a leading provider of devices and systems for the preparation, handling, packaging, and administration of liquid medications, Baxa manufactures and markets a wide range of healthcare products for use in hospitals, critical care units and alternate-site pharmacies. Headquartered in Englewood, Colorado, Baxa has subsidiaries and sales offices in Canada, the United Kingdom; Denmark, and Germany; and distribution partners worldwide. Further information is available at http://www.baxa.com.

Contacts:
Marian Robinson, Vice President, Marketing
Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157
Email: e-mail protected from spam bots

Maggie Chamberlin Holben, APR
Absolutely Public Relations: 303.984.9801 or 303.669.3558
Email: e-mail protected from spam bots